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Abstract
Introduction: Veterans with mental health disorders smoke at high rates, but encounter low rates 
of tobacco treatment. We sought to understand barriers and facilitators to treating tobacco use in 
VA mental health clinics.
Methods: This qualitative study was part of a trial evaluating a telephone care coordination pro-
gram for smokers using mental health services at six VA facilities. We conducted semi-structured 
interviews with 14 staff: 12 mental health clinic staff working at the parent study’s intervention 
sites (n = 6 psychiatrists, three psychologists, two social workers, one NP), as well as one psych-
iatrist and one psychologist on the VA’s national tobacco advisory committee. Interviews were 
transcribed and inductively coded to identify themes.
Results: Five “barriers” themes emerged: (1) competing priorities, (2) patient challenges/resist-
ance, (3) complex staffing/challenging cross-discipline coordination, (4) mixed perceptions about 
whether tobacco is a mental health care responsibility, and (5) limited staff training/comfort in 
treating tobacco. Five “facilitators” themes emerged: (1) reminding mental health staff about 
tobacco, (2) staff belief in the importance of addressing tobacco, (3) designating a cessation medi-
cation prescriber, (4) linking tobacco to mental health outcomes and norms, and (5) limiting mental 
health staff burden.
Conclusions: VA mental health staff struggle with knowing that tobacco use is important, but they 
face competing priorities, encounter patient resistance, are conflicted on their role in addressing 
tobacco, and lack tobacco training. They suggested strategies at multiple levels that would help 
overcome those barriers that can be used to design interventions that improve tobacco treatment 
delivery for mental health patients.
Implications: This study builds upon the existing literature on the high rates of smoking, but low 
rates of treatment, in people with mental health diagnoses. This study is one of the few qualitative 
evaluations of mental health clinic staff perceptions of barriers and facilitators to treating tobacco. 
The study results provide a multi-level framework for developing strategies to improve the imple-
mentation of tobacco treatment programs in mental health clinics.
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Introduction
People with mental health conditions are significantly more likely 
to smoke than people in the general population.1–3 The American 
Psychiatric Association’s (APA) practice guidelines for the treatment 
of nicotine dependence recommends routine tobacco screening of 
psychiatric patients and offering treatment to those interested in 
quitting.4 Unfortunately, national rates of tobacco screening and 
treatment in mental health settings are low,4,5 and lack of support 
from health care providers is a major barrier to abstinence in smok-
ers with mental health conditions.6
To address the limited provision of tobacco treatment in men-
tal health settings, we previously conducted a study evaluating the 
implementation of a telephone care coordination program for smok-
ers receiving mental health care at Veterans Health Administration 
(VA) facilities (the “TeleQuitMH” trial).7 Mental health clinic staff 
could refer their patients to the program using a quick consult in the 
electronic medical record (EMR). The program proactively reached 
out to patients to offer mailed cessation medications and telephone 
counseling (either specialized multisession counseling designed for 
patients with mental health disorders or warm-transfer to a state 
quitline for counseling). Long-term quit rates were good in both 
groups (26% in the specialized arm, 18% in the quitline arm), yet 
referrals from providers were lower than expected. Most providers 
did not refer any patients, and among those who did refer, 45% 
referred only one patient.
Prior research has examined barriers and facilitators to imple-
menting tobacco treatment in mental health and substance use treat-
ment programs. At the policy or organizational level, Muilenburg 
et al. found that the presence of financial incentives to treat tobacco 
and that having fewer organizational obstacles to tobacco treatment 
were associated with greater adoption of tobacco treatment in addic-
tion treatment programs.8 In a qualitative study, Pagano et al. found 
that addiction treatment program directors reported multiple organ-
izational barriers to providing tobacco treatment, including limited 
resources (eg, insurance coverage for NRT), structural and environ-
mental obstacles (eg, smoking sheds nearby), and a lack of attention 
to tobacco use in addiction treatment culture.9 Additional research 
has similarly found that organizational cultures that value smok-
ing cessation enhance the likelihood of tobacco treatment programs 
being implemented and sustained in mental health or substance 
abuse programs.6,10,11
At the visit or individual level, a national study of tobacco use 
screening and treatment by outpatient psychiatrists in the United 
States found that as visit length increased, the odds of being screened 
for tobacco increased.5 Consistent with this finding, Knudsen et al. 
found that competing demands for staff time reduced odds of sus-
taining tobacco services in addiction treatment programs,12 and 
Malte et  al. reported that time limitations was the most common 
barrier reported by providers to integrating tobacco treatment into 
routine care for posttraumatic stress disorder.13 Individual provider 
knowledge, beliefs, and attitudes have also consistently been shown 
to impact the implementation of tobacco treatment in mental health 
and substance use treatment settings. Provider factors associated with 
reduced implementation or provision of tobacco treatment include 
views that tobacco is a low priority for their patients,14 limited train-
ing or self-efficacy in addressing tobacco,11,15 fear that tobacco ces-
sation will negatively impact mental health or substance use,11,16 and 
the perception that patients are not interested in quitting.9,17
The majority of research examining factors that enhance or 
impede the delivery of tobacco treatment for mental health patients 
has been conducted in addiction treatment settings and has used 
quantitative methods, with potentially predictive factors chosen by 
investigators. In response to the low number of referrals received 
in the TeleQuitMH trial described above, we conducted qualitative 
interviews with VA mental health clinic staff and tobacco leadership 
to learn their perspectives about challenges and potential facilitators 
to addressing tobacco in VA mental health clinics.
Methods
Setting
The parent trial’s tobacco care coordination program was imple-
mented at six VA facilities in the Northeastern United States. These 
VA facilities function as staff-model managed care organizations. 
Each facility included one or more medical centers and community 
outpatient clinics. The facilities use a common electronic medical rec-
ord (EMR) that includes reminders for smoking cessation screening 
and treatment. Each facility is held accountable for their perform-
ance on the clinical reminders, but at most sites the primary care pro-
vider is responsible for completing the smoking cessation reminder. 
The current interview sub-study was approved by the Institutional 
Review Board (IRB) and the Research and Development Committee 
at the parent study’s main site, where the interview procedures were 
conducted.
Participants and Recruitment
Purposeful sampling18 was used to identify and recruit participants 
working in specific roles related to mental health care and tobacco 
at the VA. We were interested in interviewing four main categories of 
mental health clinic providers at the parent study’s intervention sites: 
psychiatry, psychology, social work, and mental health nursing. We 
were also interested in speaking with national VA mental health care 
leaders and mental health providers who serve on the VA’s national 
tobacco advisory committee (which helps provide direction and set 
tobacco policy at the VA) to understand the perspectives of VA men-
tal health care and tobacco leadership.
Potential interviewees were identified using mental health clinic 
staff lists at three of the parent study’s intervention sites: the site 
with the largest number of referrals, the site with the lowest number 
of referrals, and a site in the middle in terms of referral rates. From 
these lists, we invited five psychologists, five psychiatrists, one nurse 
practitioner, and two social workers to participate in an interview. 
We used the membership list for the VA’s tobacco advisory commit-
tee to identify a psychiatrist and a psychologist to invite for an inter-
view. We used the organizational chart for the VA’s national mental 
health care leadership committee to identify six members to invite 
for interviews (four psychologists, two psychiatrists). The positions 
and titles of the members of the VA tobacco and mental health lead-
ership committees invited to participate are not reported here to pro-
tect their identities.
Staff were invited to participate in an interview via institutional 
email, with up to three follow-up emails for non-respondents. 
Table 1 shows the interview response rates. Eighty percent of men-
tal health clinic staff invited to participate completed an interview, 
and both invited members of the VA’s tobacco advisory committee 
completed an interview. No members of the VA’s national mental 
health leadership agreed to participate. The two who provided a 
refusal reason cited that they did not feel they had a role in address-
ing tobacco.
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The final interview sample (N  =  14) included six psychiatrists 
(one female, five male), five psychologists (two female, three male), 
two social workers (one female, one male), and a female mental 
health nurse practitioner who worked at the study’s intervention 
sites. The sample also included one psychiatrist and one psychologist 
(both male) on the VA’s national tobacco advisory committee. We 
anticipated further sampling if needed after our initial round of cod-
ing and analysis. However, the 14 interviews were similar in content 
and emergent themes, and we believe additional interviews would 
not have generated new insights.
Interview Procedures
Interviews were conducted by two investigators (ESR, CG) and three 
graduate students. Interviews were conducted in-person for local 
staff or over the phone for remote staff. To minimize interviewee 
burden, interviews were designed to take no more than 20 minutes. 
We developed a semi-structured interview guide that assessed inter-
viewee perceptions toward the importance of treating tobacco in 
mental health patients, the role of mental health providers in treating 
tobacco, and barriers and facilitators toward screening and treating 
tobacco in VA mental health treatment settings. Interviews were digi-
tally recorded and transcribed verbatim.
Analyses
We used a three-step group coding process to analyze the tran-
scripts.19 Investigators first read four transcripts together and used 
open-coding to develop an initial codebook with code names, mean-
ings and examples. The investigators then applied the codebook to 
the remainder of the transcripts and held discussions to achieve con-
sensus on coding and update the codebook. Once all transcripts were 
coded using the initial codebook, the investigators completed more 
focused coding to identify code clusters, relationships among codes 
and common themes. Once themes were identified, we developed a 
conceptual framework representing the barrier themes at three levels 
(eg, system, provider, visit/patient) and how the themes interact to 
influence tobacco screening and treatment delivery.
Results
Barriers
Figure 1 shows the conceptual representation of the barrier themes 
that emerged during the interviews. These barriers and their inter-
actions are discussed in detail below (in order of their frequency 
reported during interviews).
Theme 1: Competing Clinical Priorities and Immediate Patient 
Crises during a Visit
The most common tobacco treatment barrier—endorsed during 13 
interviews—was the issue of competing priorities during a patient 
visit. Staff expressed that it is not always feasible or appropriate to 
spend time on tobacco when patients are facing immediate threats to 
safety (eg, homelessness, suicidality) or urgent psychiatric needs (eg, 
psychosis). One psychiatrist spoke of the conflict between believing 
that tobacco is important and the need to respond to psychiatric 
emergencies: “I think that [addressing tobacco] is important but is 
probably a different level of priority depending on the patient. If you 
are seeing a patient because they are psychotic and suicidal…you 
know that their use of tobacco is less pressing.” Similarly, a social 
worker expressed that: “The day to day-ness of it all just means that 
only the immediate priorities and crises are what people are focused 
on and [tobacco] is just going to recede.” We heard from one psych-
iatrist that competing priorities can be especially challenging in a 
walk-in mental health treatment setting where patients are more 
likely to be facing a psychiatric emergency.
In addition to competing patient priorities that occur during a 
visit, three interviewees reported competing priorities at the organ-
izational level that determine what must be covered during the visit. 
For example, a psychiatrist expressed that they are held account-
able by the facility for non-tobacco performance, such as completing 
depression and suicide screens. Once staff have finished addressing 
patient emergencies and the performance measure responsibilities, 
they feel they do not have time to address tobacco.
Theme 2: Patient Challenges and Resistance to Quitting and/or 
to Treatment
The second most common theme endorsed during nine interviews 
was the perception of patient barriers to tobacco treatment. These 
barriers included patient use of smoking to relieve symptoms or 
improve mood, lack of patient interest in quitting, and patient refusal 
of treatment when offered. Four staff reported that mental health 
providers may be reluctant to address tobacco because they fear 
it would negatively impact mental health or substance abuse. For 
example, a social worker said: “Our culture is that we have a lot of 
Vets with substance abuse problems and they are just so difficult and 
require so much work that no one really wants to jeopardize that. 
They all figure they can confront smoking in the future.” A psych-
ologist gave a patient example of his concerns: “You know [patient] 
has nothing in his life, is having such a hard time, but smoking calms 
him down, says smoking calms him down, you know rather smoke 
than take another medication.”
Table 1. Interview Response and Participation Rates
Invited Non-response Refusal Completed interview Participation rate
National Mental Health Leadership
 Psychologist 4 2 2 0 0%
 Psychiatrist 2 2 0 0 0%
National Tobacco Leadership
 Psychologist 1 0 0 1 100%
 Psychiatrist 1 0 0 1 100%
Mental Health Clinic Staff
 Psychologist 5 0 1 4 80%
 Psychiatrist 5 0 0 5 100%
 Nurse Practitioner 1 0 0 1 100%
 Social Worker 2 0 0 2 100%
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Eight interviewees expressed that even when providers broach 
the topic of tobacco and quitting, some patients are not interested 
in trying to quit, find the prospect of quitting to be too challenging, 
and refuse assistance. Four interviewees discussed patients with ser-
ious mental illness (eg, schizophrenia) or substance abuse as being 
especially challenging to engage in treatment or to help quit. A social 
worker said: “The acute inpatient folks have been smoking for a 
very, very long time. They are constantly offered smoking cessation 
services but always opt out. And then those with other substance 
abuse – those are the hardest. Along with those with serious men-
tal illness. Just the very nature of living makes it very, very hard to 
tackle smoking in the midst of these of these challenges. They are 
just in the business of staying alive and putting one foot in front of 
the other.” This patient resistance and provider experience with this 
resistance was causing providers to refrain from addressing tobacco 
and was harming provider self-efficacy in helping their patients. One 
psychiatrist noted that providers can experience “referral fatigue,” 
such that they grow weary of offering tobacco treatment after years 
of patient refusals.
Theme 3: Complex Clinic Staffing, Privileges and Cross-
Discipline Coordination
A third major theme that emerged during 10 interviews was the issue 
that mental health clinics have diverse and complex staffing, which 
poses a barrier to creating a single, comprehensive tobacco treatment 
approach for the clinic. A clinic can be comprised of psychiatrists, 
psychologists, social workers, peer counselors, nurses, and non-
clinical staff such as housing or employment specialists. We heard 
that some staff (eg, social workers, vocational specialists) do not use 
the EMR in their work and therefore would not see tobacco screen-
ing reminders or document when they know a patient is a smoker, 
and many staff do not have the ability to generate treatment consults 
(eg, psychologists). Additionally, three interviewees reported that 
staff may not interact or communicate with staff outside of their dis-
cipline. A psychologist expressed that: “To some degree we need bet-
ter communication and more integration between our psychologists, 
psychiatrists, and rehab-focused staff. Certainly the idea of medica-
tions may seem foreign to many. And so many don’t do anything in 
[the EMR] at all and just are not going to be comfortable making 
referrals or putting in orders.” Therefore, initiating and coordinating 
guideline-concordant tobacco treatment (eg, screening, medications, 
behavioral counseling) would require some mental health clinic staff 
to learn and use new procedures, as well as coordinate with psy-
chiatrists or nurse practitioners for medication prescriptions. This 
coordination process was perceived as burdensome or confusing for 
four interviewees, as one social worker told us: “I really can’t even 
begin to think about medications. One more thing for me to have to 
follow-up on, and I’m not sure how the psychiatrists will review and 
monitor.” These discipline and coordination factors appeared to con-
tribute to some of the participants’ discomfort in addressing tobacco 
and especially to reinforce the shared belief that tobacco cessation 
was not an essential function of their jobs.
Figure 1. Conceptual framework of multi-level barriers to tobacco treatment in VA mental health clinics.
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Theme 4: Mixed Staff Perceptions about whether Tobacco is a 
Mental Health Care Responsibility
A fourth theme that was expressed during nine interviews is the cul-
ture or perception that mental health staff often view tobacco as a 
medical issue, not within a mental health provider’s scope of prac-
tice. Of note, the two providers on mental health leadership whom 
actively refused interview participation shared this perception when 
providing their reason for refusal. Six interviewees reported that 
mental health providers recognize that tobacco use is an addiction, 
and thus could be within the scope of mental health care, yet view 
tobacco use as different than other addictions. A psychiatrist told 
us that: “Tobacco in general doesn’t itself cause as many psychi-
atric sequelae as other drugs and that maybe part of why mental 
health people don’t really see [tobacco] as much as their domain.” 
Five staff reported that they viewed tobacco as something primary 
care providers are addressing or should be addressing—or at least 
that tobacco use is a “shared responsibility” between mental health 
and primary care. The fact that the facility was only holding primary 
care providers accountable for completing tobacco use screenings 
and treatment referrals reinforced the perception that tobacco is not 
a mental health clinic responsibility.
On the other hand, five interviewees viewed tobacco as some-
thing that mental health providers should “absolutely be doing.” For 
example, a psychiatrist told us that mental health providers are in 
a “unique position to be able to help their patients stop smoking,” 
because of the comorbid nature of mental health and smoking, as 
well as their addictions training and often more frequent visits with 
patients than a primary care provider.
Theme 5: Limited Staff Training and Comfort in Tobacco Use 
Treatment
Lastly, four interviewees reported that mental health staff lack for-
mal training in treating tobacco use and this lack of training con-
tributed to the perception that tobacco was not within their domain 
and to discomfort in treating tobacco. A psychiatrist told us: “I don’t 
think I  ever had a class on treating tobacco use disorder in resi-
dency, and so because of that mental health providers may feel less 
comfortable doing it…and just because it wasn’t modeled as part of 
their responsibility when they were training, they go on to not really 
see part of their responsibility when they are full-fledged providers.” 
The training gap was not unique to psychiatrists. A social worker 
reported that, “We have a diverse staff – lots of peer specialists and 
vocational rehab folks, employment specialists. And they tend to 
have even less of a health background or perspective.”
Facilitators
The interviews revealed some common themes regarding factors 
that may facilitate tobacco treatment programs in mental health 
clinic settings, many of which are directly related to the barriers 
described above.
Theme 1: Reminding Staff about Tobacco Screening and 
Treatment
Twelve interviewees believed that tobacco treatment facilitation 
should start with methods for reminding providers to screen and refer 
to tobacco treatment, because current priorities and workflow cause 
providers to forget about tobacco. One psychologist suggested that: 
“The best way – it’s just hard to imagine anyone opposed to, against 
it – is to keep it on the radar. What’s going to stop them from making 
referrals is just forgetting about it….The motivation and intention is 
there, but people just forget.” However, two providers reinforced that 
more reminders will not be enough or may impose a burden on pro-
viders, because—as one psychiatrist put it—“with all the [existing] 
reminders, we can’t even handle what we already have.”
Theme 2: Staff Belief in the Importance of Treating Tobacco Use 
in Mental Health Patients
Ten interviewees believed in the general importance of treating 
tobacco use in mental health patients and therefore that imple-
mentation efforts do not need to focus on changing attitudes about 
patient need to quit smoking. Although (as discussed above) 13 staff 
reported that they experience conflicting priorities that distract from 
the ability to address tobacco during a visit or care plan, no inter-
viewees expressed that they believe their patients should smoke.
Theme 3: Designating a Cessation Medication Prescriber
Related to the barriers that many mental health staff are not pre-
scribers, lack comfort with cessation medications, and face compet-
ing priorities to coordinate care, nine interviewees expressed that 
having designated cessation medication prescribers would make 
comprehensive tobacco treatment easier in mental health settings. 
We heard from staff and tobacco leadership that tobacco programs 
can be successful by identifying providers who agree to prescribe 
cessation medications for patients receiving behavioral cessation 
treatment from non-prescribers. For example, a psychologist at our 
study’s main site told us know that the primary care-based tobacco 
program has a single physician who prescribes for all patients who 
attend the program and that “has worked well.” This reduces the 
need for staff to identify and coordinate with a different prescriber 
for each patient.
Theme 4: Linking Tobacco Use and Mental Health Outcomes/
Priorities
We heard from four interviewees that linking tobacco use and cessa-
tion to mental health treatment and outcomes could activate more 
mental health providers in the tobacco treatment process. Doing so 
would align tobacco treatment with disciplinary norms and staff 
perceptions of their role and skillset. For example, one social worker 
told us that focusing on substance abuse recovery would be “a nat-
ural fit” because “after all, nicotine is a substance.” A psychiatrist 
suggested that we generate interest among psychiatrists by linking 
smoking cessation to metabolic syndrome associated with atypical 
anti-psychotics, because providers “have so little success dealing 
with this issue, that to begin able to remove at least one contributing 
agent (smoking) would really be great.”
Theme 5: Limiting Provider and Staff Burden
We heard from six interviewees that efforts to implement tobacco 
treatment need to limit provider and staff burden. A social worker 
reported that: “I wonder if we should try to do as much of this as pos-
sible outside the visit. Then I’d be happy to remind them and reinforce 
and then check back in with them.” A psychiatrist and psychologist 
liked that our parent study’s telephone program had an easy con-
sult process through the EMR, because—as the psychiatrist put it—
“when things get really busy, there are not extra hoops [to refer].”
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Additional Suggestions
Although not recurring themes, two interviewees provided sugges-
tions to improve the implementation of tobacco treatment in mental 
health clinics. The mental health nurse practitioner suggested that 
efforts could be made to motivate patients to request treatment from 
their mental health providers, so that tobacco treatment programs 
do not rely only on providers to initiate the conversation. She recom-
mended that: “You could definitely do something to get the patients 
to ask about [treatment]. I’ve used the plasma TV for health educa-
tion things and it’s actually ended up being helpful – patients actually 
watch that and then come in and ask about what they saw.” Lastly, 
one social worker suggested that tobacco treatment programs could 
employ VA peer specialists who “have a history of mental illness and 
are now embedded in mental health clinics, substance abuse clinics, 
and residential programs.” She suggested that “peers are more effect-
ive in talking to the veterans about stopping drinking and drugging, 
or about coming into appointments and following up… perhaps this 
model can also be used for smoking cessation.”
Discussion
This study identified five major themes related to barriers to treating 
tobacco use in VA mental health clinics. Similar to results found by 
Malte et  al.13 and others12,14,20 the most common barrier was com-
peting priorities or lack of time. Interviewees reported that compet-
ing priorities were especially challenging in an environment where 
administrators and/or mental health care cultures do not prioritize 
tobacco treatment. Of note, our recruitment process found that the 
two VA mental health leaders who actively declined an interview did so 
because they did not feel they have a role in addressing tobacco – rein-
forcing the interview finding that VA mental health providers do not 
view tobacco treatment as falling within the scope of routine mental 
health practice. The VA prioritizes treating tobacco use nationally21 but 
places the responsibility in primary care. Therefore, while interviewees’ 
organizational setting (ie, the VA) prioritizes tobacco, their immediate 
work environment (ie, the clinic) does not—suggesting that the imme-
diate work environment had a greater impact on tobacco treatment 
behaviors than the broader organizational culture and policies.
Our interviews also found that mental health staff experience 
or perceive patient resistance to quitting and to treatment—a bar-
rier that has been reported previously9,17,20 and that can nega-
tively impact providers’ willingness or ability to address tobacco. 
Providers’ willingness and ability to address tobacco was further 
hindered by lack of training in treating tobacco, which is consistent 
with prior research.12,15,22 Our interviews revealed that this training 
deficit extends beyond psychiatrists to include non-clinical staff who 
frequently interact with mental health patients but may lack train-
ing in health care. A recent systematic review of barriers to quitting 
among mental health populations concluded that smokers with men-
tal health conditions would benefit from their providers being bet-
ter trained in tobacco assessment and treatment;6 thus implementing 
tobacco training for mental health clinic staff is likely to be wel-
comed by both staff and patients.
While some findings are consistent with existing literature, the 
study also produced new insights. Interviewees expressed that the 
diversity of mental health clinic staffing poses problems in providing 
comprehensive tobacco treatment to patients, such that some clinic 
staff do not use the EMR, are unable to electronically refer patients 
to tobacco treatment, do not have the ability to prescribe cessation 
medications, and do not have routines for coordinating with medical 
staff. Therefore, a single mental health clinic may require multiple 
strategies for implementing tobacco treatment, depending on the 
work practices and clinical privileges of different staff.
The overall pattern of results suggests that mental health clinics 
face multiple interacting barriers to treating tobacco (Figure 1) and 
that implementation strategies targeting just one barrier will likely 
not be sufficient. For example, although competing priorities/time 
constraints was the most common treatment barrier noted by inter-
viewees, there were multiple determinants of these competing issues, 
including provider (lack of training, comfort), organizational (men-
tal health care priorities, culture) and patient (crises, lack of interest 
in quitting) factors. The pattern of findings is similar to those found 
in addiction treating settings, both in the U.S. and internationally, 
suggesting that there is remarkable pervasiveness and persistence in 
challenges to systematic implementation of tobacco treatment for 
persons with mental health diagnoses.
Our findings have implications for future research and develop-
ment of strategies to implement tobacco treatment in mental health 
care settings. At the organizational level, mental health clinics should 
clarify the role of clinic staff in the tobacco treatment process and 
resolve provider concerns about competing priorities; for example, 
as has been successful in primary care, incorporating reminders to 
address tobacco use in EMR-driven and non-EMR-driven clinic 
workflow and include tobacco screening in staff performance meas-
urement.23 Clinics may also benefit from systems that allow staff 
without treatment privileges to easily refer patients to tobacco 
treatment and to coordinate with medical providers for cessation 
medications. In our discussion of potential treatment facilitators, 
interviewees reported that designating a cessation medical prescriber 
for the clinic may help alleviate barriers to providing cessation 
pharmacotherapy and alleviate non-prescriber concerns about medi-
cation responsibilities and management. In this study, mental health 
staff often viewed tobacco as a primary care responsibility. Future 
efforts may benefit from learning whether primary care providers 
would appreciate having more tobacco treatment involvement, sup-
port, and expertise from mental health providers, and how these two 
disciplines can work together to treat tobacco.
At the provider level, clinics can implement staff training on 
tobacco treatment, such as the evidence-based training curricu-
lum for psychiatrists (Psychiatry Rx for Change) that could also be 
adapted for non-psychiatrist staff.24,25 Our findings about potential 
treatment facilitators suggest that trainings may be enhanced by 
leveraging staff’s existing positive attitudes about tobacco cessa-
tion, linking cessation to mental health treatment norms and out-
comes, countering misperceptions about the inability or harms of 
patients with severe mental illness or substance abuse to quit,26 and 
teaching methods for engaging resistant patients into treatment. 
Patient engagement in treatment and quitting (and therefore pro-
vider willingness to treat) may be enhanced by addressing barriers to 
quitting identified by mental health patients, such as stress manage-
ment, symptom management, self-efficacy, and identity/belonging.6 
Additionally, for patients who were dealing with immediate crises 
during their visit that precluded a discussion about tobacco, clinics 
can implement strategies to engage the patients into tobacco care 
when they are stable, such as through proactive telephone outreach 
between visits.27
The overall pattern of results also supports the implementation 
of proactive tobacco treatment programs that do not rely on refer-
rals from mental health providers.27 Proactive tobacco treatment has 
been shown to increase population-level abstinence rates in primary 
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care28 and socioeconomically disadvantaged populations.29 A recent 
secondary analysis of proactive tobacco treatment in VA primary 
care found that primary care patients with a mental health diagno-
sis did not have significantly different abstinence rates than patients 
receiving usual care. However, authors noted that patients a men-
tal health diagnosis in their sample had frequent medical visits and 
reported receiving recent cessation advice and treatment.28 In mental 
health clinics, in contrast, where patients do not routinely receive 
tobacco cessation advice and treatment, proactive tobacco treatment 
may benefit smokers with a mental health diagnosis by overcoming 
many of the barriers identified in the current study.
Limitations
Limitations of the study include the fact that interviews were only 
conducted with VA staff, and results may not generalize outside the 
VA. Interviewees were salaried staff in an integrated health care 
system. Private practice providers may encounter different experi-
ences and motivations for treating tobacco, such as bonus payment 
opportunities for meeting federal smoking cessation quality meas-
ures.30 Another limitation is the lack of representation of VA men-
tal health leadership in the interview sample. Findings may reflect 
provider perceptions about organizational culture and priorities, 
and the study does not have data on mental health leadership views 
or information about executive-level barriers/facilitators to tobacco 
treatment. Lastly, we did not collect information about the smoking 
status of interviewees, which may impact their views toward treating 
patients for tobacco use.9,15
Conclusions
VA mental health staff struggle with knowing that tobacco use in 
patients with mental health conditions is important, but they are 
conflicted on their role in the cessation process, encounter patient 
resistance to treatment, lack training and comfort in addressing 
tobacco, and face competing demands for their time. Implementation 
interventions are needed that address these multi-level, interacting 
treatment barriers to improve the delivery of tobacco treatment to 
this high-risk population.
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